文献速递腹部MR

单发原发性肝脏恶性肿瘤的根治性切除:肝脏影像报告和数据系统LR-M类别预示更差预后

Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis.
PubMed 文献 · AJR Am J Roentgenol · 2017-06-28

研究纳入225例慢性肝病患者,对单发肝脏恶性肿瘤在钆塞酸增强MRI后按LI-RADS分类,分析术前分类与根治性切除后无病生存的关系。两位阅片者分类显示LR-M病变无病生存显著差于LR-3/4或LR-5,而LR-3/4与LR-5之间无显著差异。结论提示术前LR-M可能预示更差预后。

要点

  • 术前MRI按LI-RADS分类为LR-M的单发肝脏恶性肿瘤,根治性切除后无病生存显著差于LR-3/4或LR-5。
  • LR-3/4与LR-5病变的无病生存无显著差异(阅片者1 P=0.301,阅片者2 P=0.291)。
  • LR-M在两位阅片者中均仅占4.9%(11/225),需注意其识别与报告。

核心结论

  • 术前分类为LR-M的肿瘤在单发肝脏恶性肿瘤根治性切除后可能预后更差,无病生存显著差于LR-3/4或LR-5。

研究设计与样本

  • 回顾性研究,2008年1月至2010年12月纳入225例慢性肝病行单发肝脏恶性肿瘤切除的患者(218例肝细胞癌、3例胆管癌、4例双表型癌),术前均行钆塞酸增强MRI,两位放射科医生回顾性按LI-RADS分类,采用Kaplan-Meier法和log-rank检验比较无病生存。

诊断标准与关键数值

  • 阅片者1分类:LR-3 2例(0.9%)、LR-4 53例(23.6%)、LR-5 159例(70.7%)、LR-M 11例(4.9%)。
  • 阅片者2分类:LR-3 6例(2.7%)、LR-4 30例(13.3%)、LR-5 178例(79.1%)、LR-M 11例(4.9%)。
  • 阅片者1的2年累积复发或死亡率:LR-3或LR-4为15.1%,LR-5为31.7%,LR-M为60%。
  • 阅片者2的2年累积复发或死亡率:LR-3或LR-4为20.6%,LR-5为29%,LR-M为54.5%。
  • LR-M与LR-3/4或LR-5的无病生存差异:两位阅片者均P<0.01;LR-3/4与LR-5差异:阅片者1 P=0.301,阅片者2 P=0.291。

临床应用与阅片要点

  • 作者认为,术前MRI分类为LR-M的单发肝脏恶性肿瘤患者根治性切除后可能预后更差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to examine the associations between preoperative Liver Imaging Reporting and Data System (LI-RADS) categories and prognosis after curative resection of single hepatic malignancies in patients with chronic liver disease.

MATERIALS AND METHODS: Between January 2008 and December 2010, 225 patients with chronic liver disease underwent resection of single hepatic malignant tumors (218 hepatocellular carcinomas, three cholangiocarcinomas, four biphenotypic carcinomas) after undergoing gadoxetic acid-enhanced MRI. Two radiologists retrospectively categorized the tumors into LI-RADS categories. Differences in disease-free survival duration between categories were analyzed by the Kaplan-Meier method with the log-rank test.

RESULTS: Reviewer 1 categorized two (0.9%) patients as having LR-3, 53 (23.6%) LR-4, 159 (70.7%) LR-5, and 11 (4.9%) LR-M lesions. The corresponding numbers for reviewer 2 were six (2.7%) LR-3, 30 (13.3%) LR-4, 178 (79.1%) LR-5, and 11 (4.9%) LR-M. The 2-year cumulative recurrence or death rates were 15.1% for lesions categorized LR-3 or LR-4 by reviewer 1, 31.7% for LR-5, and 60% for LR-M. For lesions categorized by reviewer 2 the corresponding rates were 20.6% for LR-3 or LR-4, 29% for LR-5, and 54.5% for LR-M. Disease-free survival was significantly worse among patients with lesions categorized as LR-M than for lesions categorized as LR-3 or LR-4 or as LR-5 (p < 0.01 for both reviewers). Disease-free survival did not significantly differ between patients with LR-3 or LR-4 and those with LR-5 lesions (reviewer 1, p = 0.301; reviewer 2, p = 0.291).

CONCLUSION: Patients with tumors preoperatively categorized as LR-M may have a worse prognosis than those with tumors categorized LR-3, LR-4, or LR-5 after curative resection of single hepatic malignancy.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. An C, Park S, Chung YE, et al. Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis. AJR Am J Roentgenol. 2017. PMID: 28657851. doi:10.2214/AJR.16.17478

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。